Clinical pharmacokinetics

Keyphrases

Publications

volume 63, number 7, 2024

Sarah Louise Dombernowsky, Birgitte Bentz Damholt, Michael Højby Rasmussen, Claus Sværke, Rasmus Juul Kildemoes
Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial. Clinical pharmacokinetics 63 (7) (2024)
Jérôme Alexandre, Stephane Oudard, Lisa Golmard, Luca Campedel, Mourad Mseddi, Sylvain Ladoire, Ahmed Khalil, Denis Maillet, Christophe Tournigand, Blaise Pasquiers, Françoise Goirand, Joseph Berthier, Jérôme Guitton, Charles Dariane, Florence Joly, Evanguelos Xylinas, Jean Louis Golmard, Hendy Abdoul, Alicja Puszkiel, Xavier Decleves, Edith Carton, Audrey Thomas, Michel Vidal, Olivier Huillard, Benoît Blanchet
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial. Clinical pharmacokinetics 63 (7) (2024)
Pieter-Jan De Sutter, Eline Hermans, Pieter De Cock, Jan Van Bocxlaer, Elke Gasthuys, An Vermeulen
Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults. Clinical pharmacokinetics 63 (7) (2024)
Marinda Meertens, Eline L Giraud, Maud B A van der Kleij, Kim Westerdijk, Niels A D Guchelaar, Roos F Bleckman, Amy Rieborn, Alex L T Imholz, Hans-Martin Otten, Annelie Vulink, Maartje Los, Paul Hamberg, Winette T A van der Graaf, Hans Gelderblom, Dirk Jan A R Moes, K Esther Broekman, Daan J Touw, Stijn L W Koolen, Ron H J Mathijssen, Alwin D R Huitema, Nielka P van Erp, Ingrid M E Desar, Neeltje Steeghs, null null
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort. Clinical pharmacokinetics 63 (7) (2024)
Bo-Hao Tang, Xin-Fang Zhang, Shu-Meng Fu, Bu-Fan Yao, Wei Zhang, Yue-E Wu, Yi Zheng, Yue Zhou, John van den Anker, Hai-Rong Huang, Guo-Xiang Hao, Wei Zhao
Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis. Clinical pharmacokinetics 63 (7) (2024)
Kimitaka Suetsugu, Tomohiro Shigematsu, Takahiro Nakamura, Takeshi Hirota, Ichiro Ieiri
Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation. Clinical pharmacokinetics 63 (7) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Marinda Meertens, Eline L Giraud, Maud B A van der Kleij, Kim Westerdijk, Niels A D Guchelaar, Roos F Bleckman, Amy Rieborn, Alex L T Imholz, Hans-Martin Otten, Annelie Vulink, Maartje Los, Paul Hamberg, Winette T A van der Graaf, Hans Gelderblom, Dirk Jan A R Moes, K Esther Broekman, Daan J Touw, Stijn L W Koolen, Ron H J Mathijssen, Alwin D R Huitema, Nielka P van Erp, Ingrid M E Desar, Neeltje Steeghs, null null
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort. Clinical pharmacokinetics 63 (7) (2024)
Di Zhao, Ping Huang, Li Yu, Yu He
Pharmacokinetics-Pharmacodynamics Modeling for Evaluating Drug-Drug Interactions in Polypharmacy: Development and Challenges. Clinical pharmacokinetics 63 (7) (2024)
Jen-Hao Wu, Edoardo Pennesi, Francisco Bautista, May Garrett, Kei Fukuhara, Erica Brivio, Anneke C J Ammerlaan, Franco Locatelli, Inge M van der Sluis, Claudia Rossig, Christiane Chen-Santel, Bella Bielorai, Arnaud Petit, Jan Starý, Cristina Díaz-de-Heredia, Susana Rives, Aengus O'Marcaigh, Carmelo Rizzari, Gernot Engstler, Karsten Nysom, Alba Rubio-San-Simón, Benedicte Bruno, Yves Bertrand, Benoît Brethon, Fanny Rialland, Geneviève Plat, Uta Dirksen, Lucie Sramkova, Christian Michel Zwaan, Alwin D R Huitema
Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059. Clinical pharmacokinetics 63 (7) (2024)
Niels A D Guchelaar, Stefan A J Buck, Leni van Doorn, Koen G A M Hussaarts, Yorick Sandberg, Annemieke van der Padt-Pruijsten, Robbert J van Alphen, Laura Poppe-Manenschijn, Isolde Vleut, Peter de Bruijn, Roelof W F van Leeuwen, Bianca Mostert, Ferry A L M Eskens, Esther Oomen-de Hoop, Stijn L W Koolen, Ron H J Mathijssen
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study. Clinical pharmacokinetics 63 (7) (2024)
Bo-Hao Tang, Xin-Fang Zhang, Shu-Meng Fu, Bu-Fan Yao, Wei Zhang, Yue-E Wu, Yi Zheng, Yue Zhou, John van den Anker, Hai-Rong Huang, Guo-Xiang Hao, Wei Zhao
Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis. Clinical pharmacokinetics 63 (7) (2024)
Niels A D Guchelaar, Stefan A J Buck, Leni van Doorn, Koen G A M Hussaarts, Yorick Sandberg, Annemieke van der Padt-Pruijsten, Robbert J van Alphen, Laura Poppe-Manenschijn, Isolde Vleut, Peter de Bruijn, Roelof W F van Leeuwen, Bianca Mostert, Ferry A L M Eskens, Esther Oomen-de Hoop, Stijn L W Koolen, Ron H J Mathijssen
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study. Clinical pharmacokinetics 63 (7) (2024)
Kimitaka Suetsugu, Tomohiro Shigematsu, Takahiro Nakamura, Takeshi Hirota, Ichiro Ieiri
Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation. Clinical pharmacokinetics 63 (7) (2024)
Sarah Louise Dombernowsky, Birgitte Bentz Damholt, Michael Højby Rasmussen, Claus Sværke, Rasmus Juul Kildemoes
Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial. Clinical pharmacokinetics 63 (7) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Pieter-Jan De Sutter, Eline Hermans, Pieter De Cock, Jan Van Bocxlaer, Elke Gasthuys, An Vermeulen
Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults. Clinical pharmacokinetics 63 (7) (2024)
Pieter-Jan De Sutter, Eline Hermans, Pieter De Cock, Jan Van Bocxlaer, Elke Gasthuys, An Vermeulen
Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults. Clinical pharmacokinetics 63 (7) (2024)
Jérôme Alexandre, Stephane Oudard, Lisa Golmard, Luca Campedel, Mourad Mseddi, Sylvain Ladoire, Ahmed Khalil, Denis Maillet, Christophe Tournigand, Blaise Pasquiers, Françoise Goirand, Joseph Berthier, Jérôme Guitton, Charles Dariane, Florence Joly, Evanguelos Xylinas, Jean Louis Golmard, Hendy Abdoul, Alicja Puszkiel, Xavier Decleves, Edith Carton, Audrey Thomas, Michel Vidal, Olivier Huillard, Benoît Blanchet
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial. Clinical pharmacokinetics 63 (7) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Di Zhao, Ping Huang, Li Yu, Yu He
Pharmacokinetics-Pharmacodynamics Modeling for Evaluating Drug-Drug Interactions in Polypharmacy: Development and Challenges. Clinical pharmacokinetics 63 (7) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Sarah Louise Dombernowsky, Birgitte Bentz Damholt, Michael Højby Rasmussen, Claus Sværke, Rasmus Juul Kildemoes
Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial. Clinical pharmacokinetics 63 (7) (2024)
Marinda Meertens, Eline L Giraud, Maud B A van der Kleij, Kim Westerdijk, Niels A D Guchelaar, Roos F Bleckman, Amy Rieborn, Alex L T Imholz, Hans-Martin Otten, Annelie Vulink, Maartje Los, Paul Hamberg, Winette T A van der Graaf, Hans Gelderblom, Dirk Jan A R Moes, K Esther Broekman, Daan J Touw, Stijn L W Koolen, Ron H J Mathijssen, Alwin D R Huitema, Nielka P van Erp, Ingrid M E Desar, Neeltje Steeghs, null null
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort. Clinical pharmacokinetics 63 (7) (2024)
Jen-Hao Wu, Edoardo Pennesi, Francisco Bautista, May Garrett, Kei Fukuhara, Erica Brivio, Anneke C J Ammerlaan, Franco Locatelli, Inge M van der Sluis, Claudia Rossig, Christiane Chen-Santel, Bella Bielorai, Arnaud Petit, Jan Starý, Cristina Díaz-de-Heredia, Susana Rives, Aengus O'Marcaigh, Carmelo Rizzari, Gernot Engstler, Karsten Nysom, Alba Rubio-San-Simón, Benedicte Bruno, Yves Bertrand, Benoît Brethon, Fanny Rialland, Geneviève Plat, Uta Dirksen, Lucie Sramkova, Christian Michel Zwaan, Alwin D R Huitema
Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059. Clinical pharmacokinetics 63 (7) (2024)
Marinda Meertens, Eline L Giraud, Maud B A van der Kleij, Kim Westerdijk, Niels A D Guchelaar, Roos F Bleckman, Amy Rieborn, Alex L T Imholz, Hans-Martin Otten, Annelie Vulink, Maartje Los, Paul Hamberg, Winette T A van der Graaf, Hans Gelderblom, Dirk Jan A R Moes, K Esther Broekman, Daan J Touw, Stijn L W Koolen, Ron H J Mathijssen, Alwin D R Huitema, Nielka P van Erp, Ingrid M E Desar, Neeltje Steeghs, null null
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort. Clinical pharmacokinetics 63 (7) (2024)
Jen-Hao Wu, Edoardo Pennesi, Francisco Bautista, May Garrett, Kei Fukuhara, Erica Brivio, Anneke C J Ammerlaan, Franco Locatelli, Inge M van der Sluis, Claudia Rossig, Christiane Chen-Santel, Bella Bielorai, Arnaud Petit, Jan Starý, Cristina Díaz-de-Heredia, Susana Rives, Aengus O'Marcaigh, Carmelo Rizzari, Gernot Engstler, Karsten Nysom, Alba Rubio-San-Simón, Benedicte Bruno, Yves Bertrand, Benoît Brethon, Fanny Rialland, Geneviève Plat, Uta Dirksen, Lucie Sramkova, Christian Michel Zwaan, Alwin D R Huitema
Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059. Clinical pharmacokinetics 63 (7) (2024)
Sarah Louise Dombernowsky, Birgitte Bentz Damholt, Michael Højby Rasmussen, Claus Sværke, Rasmus Juul Kildemoes
Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial. Clinical pharmacokinetics 63 (7) (2024)

volume 63, number 8, 2024

Wan-Yu Chu, Maaike Nijman, Raymond Stegeman, Johannes M P J Breur, Nicolaas J G Jansen, Joppe Nijman, Kim van Loon, Erik Koomen, Karel Allegaert, Manon J N L Benders, Thomas P C Dorlo, Alwin D R Huitema, null null
Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease. Clinical pharmacokinetics 63 (8) (2024)
Florence Rivals, Sylvain Goutelle, Cyrielle Codde, Romain Garreau, Laure Ponthier, Pierre Marquet, Tristan Ferry, Marc Labriffe, Alexandre Destere, Jean Baptiste Woillard
A Machine Learning Algorithm to Predict the Starting Dose of Daptomycin. Clinical pharmacokinetics 63 (8) (2024)
Thi A Nguyen, Ricky H Chen, Bryson A Hawkins, David E Hibbs, Hannah Y Kim, Nial J Wheate, Paul W Groundwater, Sophie L Stocker, Jan-Willem C Alffenaar
Can we Predict Drug Excretion into Saliva? A Systematic Review and Analysis of Physicochemical Properties. Clinical pharmacokinetics 63 (8) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Florin M Musteata
Dosing Adjustments in Cases of Altered Plasma Protein Binding are Most Needed for Drugs with a Volume of Distribution Below 1.3 L/kg. Clinical pharmacokinetics 63 (8) (2024)
Wan-Yu Chu, Maaike Nijman, Raymond Stegeman, Johannes M P J Breur, Nicolaas J G Jansen, Joppe Nijman, Kim van Loon, Erik Koomen, Karel Allegaert, Manon J N L Benders, Thomas P C Dorlo, Alwin D R Huitema, null null
Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease. Clinical pharmacokinetics 63 (8) (2024)
Thi A Nguyen, Ricky H Chen, Bryson A Hawkins, David E Hibbs, Hannah Y Kim, Nial J Wheate, Paul W Groundwater, Sophie L Stocker, Jan-Willem C Alffenaar
Can we Predict Drug Excretion into Saliva? A Systematic Review and Analysis of Physicochemical Properties. Clinical pharmacokinetics 63 (8) (2024)
Ahmed Bayoumy Bayoumy, A R Ansari, C J J Mulder, K Schmiegelow, Timothy Florin, N K H De Boer
Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy. Clinical pharmacokinetics 63 (8) (2024)
Ahmed Bayoumy Bayoumy, A R Ansari, C J J Mulder, K Schmiegelow, Timothy Florin, N K H De Boer
Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy. Clinical pharmacokinetics 63 (8) (2024)
Ahmed Bayoumy Bayoumy, A R Ansari, C J J Mulder, K Schmiegelow, Timothy Florin, N K H De Boer
Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy. Clinical pharmacokinetics 63 (8) (2024)
Tong Yuan, Fulin Bi, Kuan Hu, Yuqi Zhu, Yan Lin, Jin Yang
Clinical Trial Data-Driven Risk Assessment of Drug-Drug Interactions: A Rapid and Accurate Decision-Making Tool. Clinical pharmacokinetics 63 (8) (2024)
Fiorenza Ferrari, Paola Milla, Marco Sartori, Christian Zanza, Manfredi Tesauro, Yaroslava Longhitano, Annalisa De Silvestri, Chiara Abbruzzese, Silvia De Rosa, Sergio Lassola, Sara Samoni, Alessandra Brendolan, Monica Zanella, Vittorio Scaravilli, Giacomo Grasselli, Silvia Arpicco, Claudio Ronco
Antibiotics Removal during Continuous Renal Replacement Therapy in Septic Shock Patients: Mixed Modality Versus "Expanded Haemodialysis". Clinical pharmacokinetics 63 (8) (2024)
Thi A Nguyen, Ricky H Chen, Bryson A Hawkins, David E Hibbs, Hannah Y Kim, Nial J Wheate, Paul W Groundwater, Sophie L Stocker, Jan-Willem C Alffenaar
Can we Predict Drug Excretion into Saliva? A Systematic Review and Analysis of Physicochemical Properties. Clinical pharmacokinetics 63 (8) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Rui Li, Emi Kimoto, Yi-An Bi, David Tess, Manthena V S Varma
Physiologically Based Pharmacokinetic Model of OATP1B Substrates with a Nonlinear Mixed Effect Approach: Estimating Empirical In Vitro-to-In Vivo Scaling Factors. Clinical pharmacokinetics 63 (8) (2024)
Fiorenza Ferrari, Paola Milla, Marco Sartori, Christian Zanza, Manfredi Tesauro, Yaroslava Longhitano, Annalisa De Silvestri, Chiara Abbruzzese, Silvia De Rosa, Sergio Lassola, Sara Samoni, Alessandra Brendolan, Monica Zanella, Vittorio Scaravilli, Giacomo Grasselli, Silvia Arpicco, Claudio Ronco
Antibiotics Removal during Continuous Renal Replacement Therapy in Septic Shock Patients: Mixed Modality Versus "Expanded Haemodialysis". Clinical pharmacokinetics 63 (8) (2024)
Wan-Yu Chu, Maaike Nijman, Raymond Stegeman, Johannes M P J Breur, Nicolaas J G Jansen, Joppe Nijman, Kim van Loon, Erik Koomen, Karel Allegaert, Manon J N L Benders, Thomas P C Dorlo, Alwin D R Huitema, null null
Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease. Clinical pharmacokinetics 63 (8) (2024)
Ahmed Bayoumy Bayoumy, A R Ansari, C J J Mulder, K Schmiegelow, Timothy Florin, N K H De Boer
Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy. Clinical pharmacokinetics 63 (8) (2024)
Wan-Yu Chu, Maaike Nijman, Raymond Stegeman, Johannes M P J Breur, Nicolaas J G Jansen, Joppe Nijman, Kim van Loon, Erik Koomen, Karel Allegaert, Manon J N L Benders, Thomas P C Dorlo, Alwin D R Huitema, null null
Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease. Clinical pharmacokinetics 63 (8) (2024)
Evan D Kharasch, Christine Hoffer, Pamela Bedynek
Intrasubject Variability in Intravenous and Oral Probes for Hepatic and First-Pass CYP3A Activity. Clinical pharmacokinetics 63 (8) (2024)